Literature DB >> 12618166

Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours.

D Querleu1, Th Papageorgiou, E Lambaudie, Y Sonoda, F Narducci, E LeBlanc.   

Abstract

OBJECTIVES: To review our experience with the laparoscopic restaging procedure of presumed early stage borderline ovarian tumours.
DESIGN: Retrospective study.
SETTING: Cancer centre. POPULATION: Thirty patients with presumed stage I borderline ovarian tumours after limited initial surgery.
METHODS: From April 1991 to May 2001, the patients were laparoscopically reassessed. The procedure involved peritoneal cytology, exploration of the peritoneal cavity, infracolic omentectomy, directed or random peritoneal biopsies, and when appropriate, contralateral oophorectomy and hysterectomy and appendectomy. Medical records were reviewed for patients' age, interval time between procedures, tumour stage, histological type, operative time, hospital stay, peri-operative complications and follow up. MAIN OUTCOME MEASURES: Seroperative and postoperative data, pathology and clinical follow up.
RESULTS: Laparoscopic restaging was completed in all 30 (100%) identified patients. The mean age was 34.8 (10.5) years; the delay between initial operation and restaging laparoscopy averaged 9.8 (6.6) weeks. The mean operative time was 165.4 (53.8) minutes, and the mean hospital stay was 2.7 (1.3) days. There were two (7.0%) major complications related directly to the procedure. Eight (26.6%) patients were upstaged. Mean follow up was 29.1 (6.6) months, all patients are alive and one (3.2%) recurrence was observed.
CONCLUSIONS: Laparoscopic approach of restaging for borderline ovarian tumours is an accurate safe procedure. It is associated with an acceptable rate of minor complications, it has similar morbidity associated with laparotomy and it minimises the incidence of infertility in the young patients. Whenever staging of borderline ovarian tumours is to be considered in an individual patient, laparoscopy provides a suitable alternative approach.

Entities:  

Mesh:

Year:  2003        PMID: 12618166

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

Review 1.  Role of minimally invasive surgery in staging of ovarian cancer.

Authors:  David A Iglesias; Pedro T Ramirez
Journal:  Curr Treat Options Oncol       Date:  2011-09

2.  Laparoscopic restaging of borderline ovarian tumors.

Authors:  E Daraï; L Tulpin; H Prugnolle; A Cortez; G Dubernard
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

Review 3.  Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.

Authors:  Frederico S Falcetta; Theresa A Lawrie; Lídia Rf Medeiros; Maria Ines da Rosa; Maria I Edelweiss; Airton T Stein; Alice Zelmanowicz; Anaelena B Moraes; Roselaine R Zanini; Daniela D Rosa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

4.  Preliminary experience with robot-assisted laparoscopic staging of gynecologic malignancies.

Authors:  R Kevin Reynolds; William M Burke; Arnold P Advincula
Journal:  JSLS       Date:  2005 Apr-Jun       Impact factor: 2.172

Review 5.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

6.  Comparison of diagnostic accuracy of transvaginal ultrasound with laparoscopy in the management of patients with adnexal masses.

Authors:  Theodoros D Theodoridis; Leonidas Zepiridis; Themistoklis Mikos; Grigoris F Grimbizis; Konstantinos Dinas; Apostolos Athanasiadis; John N Bontis
Journal:  Arch Gynecol Obstet       Date:  2009-03-05       Impact factor: 2.344

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.